Global Oral COVID-19 Drug Market Research Report 2022 - Market Study Report

Global Oral COVID-19 Drug Market Research Report 2022

Report Format: PDF | Report ID: 4889630 | Published Date: April 01, 2022

Choose License
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Tablet
    Capsule
Segment by Application
    Hospital
    Clinics
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
By Company
    Pfizer
    MSD and Ridgeback
    Shionogi
1 Oral COVID-19 Drug Market Overview
    1.1 Product Overview and Scope of Oral COVID-19 Drug
    1.2 Oral COVID-19 Drug Segment by Type
        1.2.1 Global Oral COVID-19 Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Tablet
        1.2.3 Capsule
    1.3 Oral COVID-19 Drug Segment by Application
        1.3.1 Global Oral COVID-19 Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinics
    1.4 Global Oral COVID-19 Drug Market Size Estimates and Forecasts
        1.4.1 Global Oral COVID-19 Drug Revenue 2017-2028
        1.4.2 Global Oral COVID-19 Drug Sales 2017-2028
        1.4.3 Oral COVID-19 Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral COVID-19 Drug Market Competition by Manufacturers
    2.1 Global Oral COVID-19 Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Oral COVID-19 Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Oral COVID-19 Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Oral COVID-19 Drug Manufacturing Sites, Area Served, Product Type
    2.5 Oral COVID-19 Drug Market Competitive Situation and Trends
        2.5.1 Oral COVID-19 Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Oral COVID-19 Drug Players Market Share by Revenue
        2.5.3 Global Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral COVID-19 Drug Retrospective Market Scenario by Region
    3.1 Global Oral COVID-19 Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Oral COVID-19 Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Oral COVID-19 Drug Market Facts & Figures by Country
        3.3.1 North America Oral COVID-19 Drug Sales by Country
        3.3.2 North America Oral COVID-19 Drug Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Oral COVID-19 Drug Market Facts & Figures by Country
        3.4.1 Europe Oral COVID-19 Drug Sales by Country
        3.4.2 Europe Oral COVID-19 Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Oral COVID-19 Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Oral COVID-19 Drug Sales by Region
        3.5.2 Asia Pacific Oral COVID-19 Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Oral COVID-19 Drug Market Facts & Figures by Country
        3.6.1 Latin America Oral COVID-19 Drug Sales by Country
        3.6.2 Latin America Oral COVID-19 Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Oral COVID-19 Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Oral COVID-19 Drug Sales by Country
        3.7.2 Middle East and Africa Oral COVID-19 Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Oral COVID-19 Drug Historic Market Analysis by Type
    4.1 Global Oral COVID-19 Drug Sales Market Share by Type (2017-2022)
    4.2 Global Oral COVID-19 Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Oral COVID-19 Drug Price by Type (2017-2022)
5 Global Oral COVID-19 Drug Historic Market Analysis by Application
    5.1 Global Oral COVID-19 Drug Sales Market Share by Application (2017-2022)
    5.2 Global Oral COVID-19 Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Oral COVID-19 Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Oral COVID-19 Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Pfizer Oral COVID-19 Drug Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 MSD and Ridgeback
        6.2.1 MSD and Ridgeback Corporation Information
        6.2.2 MSD and Ridgeback Description and Business Overview
        6.2.3 MSD and Ridgeback Oral COVID-19 Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 MSD and Ridgeback Oral COVID-19 Drug Product Portfolio
        6.2.5 MSD and Ridgeback Recent Developments/Updates
    6.3 Shionogi
        6.3.1 Shionogi Corporation Information
        6.3.2 Shionogi Description and Business Overview
        6.3.3 Shionogi Oral COVID-19 Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Shionogi Oral COVID-19 Drug Product Portfolio
        6.3.5 Shionogi Recent Developments/Updates
7 Oral COVID-19 Drug Manufacturing Cost Analysis
    7.1 Oral COVID-19 Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Oral COVID-19 Drug
    7.4 Oral COVID-19 Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Oral COVID-19 Drug Distributors List
    8.3 Oral COVID-19 Drug Customers
9 Oral COVID-19 Drug Market Dynamics
    9.1 Oral COVID-19 Drug Industry Trends
    9.2 Oral COVID-19 Drug Market Drivers
    9.3 Oral COVID-19 Drug Market Challenges
    9.4 Oral COVID-19 Drug Market Restraints
10 Global Market Forecast
    10.1 Oral COVID-19 Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Oral COVID-19 Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Oral COVID-19 Drug by Type (2023-2028)
    10.2 Oral COVID-19 Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Oral COVID-19 Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Oral COVID-19 Drug by Application (2023-2028)
    10.3 Oral COVID-19 Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Oral COVID-19 Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Oral COVID-19 Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Oral COVID-19 Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Oral COVID-19 Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Oral COVID-19 Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Oral COVID-19 Drug Market Competitive Situation by Manufacturers in 2021 Table 5. Global Oral COVID-19 Drug Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Oral COVID-19 Drug Sales Market Share by Manufacturers (2017-2022) Table 7. Global Oral COVID-19 Drug Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Oral COVID-19 Drug Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Oral COVID-19 Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Oral COVID-19 Drug Manufacturing Sites and Area Served Table 11. Manufacturers Oral COVID-19 Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Oral COVID-19 Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral COVID-19 Drug as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Oral COVID-19 Drug Sales by Region (2017-2022) & (K Units) Table 16. Global Oral COVID-19 Drug Sales Market Share by Region (2017-2022) Table 17. Global Oral COVID-19 Drug Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Oral COVID-19 Drug Revenue Market Share by Region (2017-2022) Table 19. North America Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units) Table 20. North America Oral COVID-19 Drug Sales Market Share by Country (2017-2022) Table 21. North America Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Oral COVID-19 Drug Revenue Market Share by Country (2017-2022) Table 23. Europe Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units) Table 24. Europe Oral COVID-19 Drug Sales Market Share by Country (2017-2022) Table 25. Europe Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Oral COVID-19 Drug Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Oral COVID-19 Drug Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Oral COVID-19 Drug Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Oral COVID-19 Drug Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Oral COVID-19 Drug Revenue Market Share by Region (2017-2022) Table 31. Latin America Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units) Table 32. Latin America Oral COVID-19 Drug Sales Market Share by Country (2017-2022) Table 33. Latin America Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Oral COVID-19 Drug Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Oral COVID-19 Drug Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Oral COVID-19 Drug Revenue Market Share by Country (2017-2022) Table 39. Global Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units) Table 40. Global Oral COVID-19 Drug Sales Market Share by Type (2017-2022) Table 41. Global Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Oral COVID-19 Drug Revenue Share by Type (2017-2022) Table 43. Global Oral COVID-19 Drug Price by Type (2017-2022) & (US$/Unit) Table 44. Global Oral COVID-19 Drug Sales (K Units) by Application (2017-2022) Table 45. Global Oral COVID-19 Drug Sales Market Share by Application (2017-2022) Table 46. Global Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Oral COVID-19 Drug Revenue Share by Application (2017-2022) Table 48. Global Oral COVID-19 Drug Price by Application (2017-2022) & (US$/Unit) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Pfizer Oral COVID-19 Drug Product Table 53. Pfizer Recent Developments/Updates Table 54. MSD and Ridgeback Corporation Information Table 55. MSD and Ridgeback Description and Business Overview Table 56. MSD and Ridgeback Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. MSD and Ridgeback Oral COVID-19 Drug Product Table 58. MSD and Ridgeback Recent Developments/Updates Table 59. Shionogi Corporation Information Table 60. Shionogi Description and Business Overview Table 61. Shionogi Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Shionogi Oral COVID-19 Drug Product Table 63. Shionogi Recent Developments/Updates Table 64. Production Base and Market Concentration Rate of Raw Material Table 65. Key Suppliers of Raw Materials Table 66. Oral COVID-19 Drug Distributors List Table 67. Oral COVID-19 Drug Customers List Table 68. Oral COVID-19 Drug Market Trends Table 69. Oral COVID-19 Drug Market Drivers Table 70. Oral COVID-19 Drug Market Challenges Table 71. Oral COVID-19 Drug Market Restraints Table 72. Global Oral COVID-19 Drug Sales Forecast by Type (2023-2028) & (K Units) Table 73. Global Oral COVID-19 Drug Sales Market Share Forecast by Type (2023-2028) Table 74. Global Oral COVID-19 Drug Revenue Forecast by Type (2023-2028) & (US$ Million) Table 75. Global Oral COVID-19 Drug Revenue Market Share Forecast by Type (2023-2028) Table 76. Global Oral COVID-19 Drug Sales Forecast by Application (2023-2028) & (K Units) Table 77. Global Oral COVID-19 Drug Sales Market Share Forecast by Application (2023-2028) Table 78. Global Oral COVID-19 Drug Revenue Forecast by Application (2023-2028) & (US$ Million) Table 79. Global Oral COVID-19 Drug Revenue Market Share Forecast by Application (2023-2028) Table 80. Global Oral COVID-19 Drug Sales Forecast by Region (2023-2028) & (K Units) Table 81. Global Oral COVID-19 Drug Sales Market Share Forecast by Region (2023-2028) Table 82. Global Oral COVID-19 Drug Revenue Forecast by Region (2023-2028) & (US$ Million) Table 83. Global Oral COVID-19 Drug Revenue Market Share Forecast by Region (2023-2028) Table 84. Research Programs/Design for This Report Table 85. Key Data Information from Secondary Sources Table 86. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Oral COVID-19 Drug Figure 2. Global Oral COVID-19 Drug Market Share by Type in 2021 & 2028 Figure 3. Tablet Product Picture Figure 4. Capsule Product Picture Figure 5. Global Oral COVID-19 Drug Market Share by Application in 2021 & 2028 Figure 6. Hospital Figure 7. Clinics Figure 8. Global Oral COVID-19 Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 9. Global Oral COVID-19 Drug Market Size (2017-2028) & (US$ Million) Figure 10. Global Oral COVID-19 Drug Sales (2017-2028) & (K Units) Figure 11. Oral COVID-19 Drug Sales Share by Manufacturers in 2021 Figure 12. Global Oral COVID-19 Drug Revenue Share by Manufacturers in 2021 Figure 13. The Global 5 and 10 Largest Oral COVID-19 Drug Players: Market Share by Revenue in 2021 Figure 14. Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 15. Global Oral COVID-19 Drug Sales Market Share by Region (2017-2022) Figure 16. Global Oral COVID-19 Drug Sales Market Share by Region in 2021 Figure 17. Global Oral COVID-19 Drug Revenue Market Share by Region (2017-2022) Figure 18. Global Oral COVID-19 Drug Revenue Market Share by Region in 2021 Figure 19. United States Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 20. Canada Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Germany Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. France Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. U.K. Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Italy Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Russia Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. China Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Japan Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. South Korea Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. India Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Australia Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. China Taiwan Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Indonesia Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Thailand Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Malaysia Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Mexico Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Brazil Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Argentina Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Turkey Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Saudi Arabia Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. UAE Oral COVID-19 Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Sales Market Share of Oral COVID-19 Drug by Type (2017-2022) Figure 42. Manufacturing Cost Structure of Oral COVID-19 Drug Figure 43. Manufacturing Process Analysis of Oral COVID-19 Drug Figure 44. Oral COVID-19 Drug Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us